Dingcong, Reymund C.
HRN: 22-45-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2023
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
01/04/2023
01/11/2023
PO
400,000iu
Q6
Oral Candidiasis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes